BACKGROUND: Cirrhotic patients have an impaired health-related quality of life (HRQOL), which is usually analysed using static paper-pencil questionnaires. The Patient Reported Outcomes Measurement Information System (PROMIS) computerised adaptive testing (CAT) are flexible, freely available, noncopyrighted, HRQOL instruments with US-based norms across 11 domains. CAT presents five to seven questions/domain depending on the patient's response, from large validated question banks. This provides brevity and precision equivalent to the entire question bank. AIM: To evaluate PROMIS CAT tools against 'legacy instruments' for cirrhotics and their informal caregivers. METHODS: A total of 200 subjects: 100 cirrhotics (70 men, 53% decompensated) and 100 caregivers were administered the PROMIS and legacy instruments [Sickness Impact Profile (SIP), Beck depression/anxiety inventories, Pittsburgh Sleep-Quality Index (PSQI) and Epworth Sleepiness scale (ESS)] concurrently. Both legacy and PROMIS results for patients were compared with caregivers and US norms. These were also compared between compensated and decompensated patients. Preference for SIP or PROMIS was inquired of a selected group (n = 70, 50% patients). Test - retest reliability was assessed in another group of 20 patients. RESULTS: Patients had significant impairment on all PROMIS domains apart from anger and anxiety compared with caregivers and US norms (P < 0.02 to <0.0001). Decompensated patients had significantly worse sleep, pain, social and physical function scores compared with compensated ones, similar to legacy instruments. There was a statistically significant correlation between PROMIS and their corresponding legacy instruments. The majority (71%) preferred PROMIS over SIP. PROMIS tools had significant test - retest reliability (ICC range 0.759-0.985) when administered 12 ± 6 days apart. CONCLUSION: PROMIS computerised adaptive testing tools had significant concurrent and discriminant validity, test - retest reliability and subject preference for assessing HRQOL in cirrhotic patients.
BACKGROUND:Cirrhoticpatients have an impaired health-related quality of life (HRQOL), which is usually analysed using static paper-pencil questionnaires. The Patient Reported Outcomes Measurement Information System (PROMIS) computerised adaptive testing (CAT) are flexible, freely available, noncopyrighted, HRQOL instruments with US-based norms across 11 domains. CAT presents five to seven questions/domain depending on the patient's response, from large validated question banks. This provides brevity and precision equivalent to the entire question bank. AIM: To evaluate PROMIS CAT tools against 'legacy instruments' for cirrhotics and their informal caregivers. METHODS: A total of 200 subjects: 100 cirrhotics (70 men, 53% decompensated) and 100 caregivers were administered the PROMIS and legacy instruments [Sickness Impact Profile (SIP), Beck depression/anxiety inventories, Pittsburgh Sleep-Quality Index (PSQI) and Epworth Sleepiness scale (ESS)] concurrently. Both legacy and PROMIS results for patients were compared with caregivers and US norms. These were also compared between compensated and decompensated patients. Preference for SIP or PROMIS was inquired of a selected group (n = 70, 50% patients). Test - retest reliability was assessed in another group of 20 patients. RESULTS:Patients had significant impairment on all PROMIS domains apart from anger and anxiety compared with caregivers and US norms (P < 0.02 to <0.0001). Decompensated patients had significantly worse sleep, pain, social and physical function scores compared with compensated ones, similar to legacy instruments. There was a statistically significant correlation between PROMIS and their corresponding legacy instruments. The majority (71%) preferred PROMIS over SIP. PROMIS tools had significant test - retest reliability (ICC range 0.759-0.985) when administered 12 ± 6 days apart. CONCLUSION: PROMIS computerised adaptive testing tools had significant concurrent and discriminant validity, test - retest reliability and subject preference for assessing HRQOL in cirrhoticpatients.
Authors: Sammy Saab; Vivian Ng; Carmen Landaverde; Sung-Jae Lee; W Scott Comulada; Jennifer Arevalo; Francisco Durazo; Steven-Huy Han; Zobari Younossi; Ronald W Busuttil Journal: Liver Transpl Date: 2011-05 Impact factor: 5.799
Authors: G Marchesini; G Bianchi; P Amodio; F Salerno; M Merli; C Panella; C Loguercio; G Apolone; M Niero; R Abbiati Journal: Gastroenterology Date: 2001-01 Impact factor: 22.682
Authors: Jasmohan S Bajaj; James B Wade; Douglas P Gibson; Douglas M Heuman; Leroy R Thacker; Richard K Sterling; R Todd Stravitz; Velimir Luketic; Michael Fuchs; Melanie B White; Debulon E Bell; HoChong Gilles; Katherine Morton; Nicole Noble; Puneet Puri; Arun J Sanyal Journal: Am J Gastroenterol Date: 2011-05-10 Impact factor: 10.864
Authors: Sammy Saab; Hillary Bownik; Noel Ayoub; Zobair Younossi; Francisco Durazo; Steven Han; Johnny C Hong; Douglas Farmer; Ronald W Busuttil Journal: Liver Transpl Date: 2011-05 Impact factor: 5.799
Authors: Rodrigo Jover; Luís Compañy; Ana Gutiérrez; Pedro Zapater; Juan Pérez-Serra; Eva Girona; José R Aparicio; Miguel Pérez-Mateo Journal: Am J Gastroenterol Date: 2003-07 Impact factor: 10.864
Authors: Fasiha Kanwal; Ian M Gralnek; Ron D Hays; Angelique Zeringue; Francisco Durazo; Steven B Han; Sammy Saab; Roger Bolus; Brennan M R Spiegel Journal: Clin Gastroenterol Hepatol Date: 2009-03-21 Impact factor: 11.382
Authors: Rachel L Richesson; W Ed Hammond; Meredith Nahm; Douglas Wixted; Gregory E Simon; Jennifer G Robinson; Alan E Bauck; Denise Cifelli; Michelle M Smerek; John Dickerson; Reesa L Laws; Rosemary A Madigan; Shelley A Rusincovitch; Cynthia Kluchar; Robert M Califf Journal: J Am Med Inform Assoc Date: 2013-08-16 Impact factor: 4.497
Authors: A D Lee; B M Spiegel; R D Hays; G Y Melmed; R Bolus; D Khanna; P P Khanna; L Chang Journal: Neurogastroenterol Motil Date: 2016-12-16 Impact factor: 3.598
Authors: Nneka N Ufere; David L O'Riordan; Kara E Bischoff; Angela K Marks; Nwamaka Eneanya; Raymond T Chung; Vicki Jackson; Steven Z Pantilat; Areej El-Jawahri Journal: J Pain Symptom Manage Date: 2019-07-19 Impact factor: 3.612
Authors: Man Hung; Judith F Baumhauer; L Daniel Latt; Charles L Saltzman; Nelson F SooHoo; Kenneth J Hunt Journal: Clin Orthop Relat Res Date: 2013-11 Impact factor: 4.176
Authors: D M Evon; J Amador; P Stewart; B B Reeve; A S Lok; R K Sterling; A M Di Bisceglie; N Reau; M Serper; S Sarkar; J K Lim; C E Golin; M W Fried Journal: Aliment Pharmacol Ther Date: 2018-01-29 Impact factor: 8.171
Authors: Jasmohan S Bajaj; Melanie B White; Ariel B Unser; Dinesh Ganapathy; Andrew Fagan; Edith A Gavis; Richard K Sterling; Douglas M Heuman; Scott Matherly; Puneet Puri; Arun J Sanyal; Velimir Luketic; Michael Fuchs; Muhammad S Siddiqui; R Todd Stravitz; Binu John; Leroy R Thacker; James B Wade Journal: Metab Brain Dis Date: 2016-06-25 Impact factor: 3.584
Authors: Eiman Nabi; Leroy R Thacker; James B Wade; Richard K Sterling; R Todd Stravitz; Michael Fuchs; Douglas M Heuman; Iliana Bouneva; Arun J Sanyal; Mohammad S Siddiqui; Velimir Luketic; Melanie B White; Pamela Monteith; Nicole A Noble; Ariel Unser; Jasmohan S Bajaj Journal: Clin Gastroenterol Hepatol Date: 2013-12-19 Impact factor: 11.382
Authors: Vishwadeep Ahluwalia; James B Wade; Melanie B White; HoChong S Gilles; Douglas M Heuman; Michael Fuchs; Edith A Gavis; Andrew Fagan; Felicia Tinsley; Dinesh Ganapathy; Leroy R Thacker; Richard K Sterling; R Todd Stravitz; Puneet Puri; Arun J Sanyal; Muhammad S Siddiqui; Scott Matherly; Velimir Luketic; Joel Steinberg; F Gerard Moeller; Jasmohan S Bajaj Journal: Liver Transpl Date: 2016-10 Impact factor: 5.799